Skip to main content
Clinical Trials/NCT01543230
NCT01543230
Terminated
Not Applicable

Ceramic on Metal Total Hip System, CoMplete™ Acetabular Hip System

DePuy Orthopaedics2 sites in 1 country58 target enrollmentFebruary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-inflammatory Degenerative Joint Disease
Sponsor
DePuy Orthopaedics
Enrollment
58
Locations
2
Primary Endpoint
Survivorship
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

The primary objective of this investigation is to evaluate survivorship at ten years. For this post approval study (PAS), a maximum acceptable hazard of revision is assumed to be a constant 1% per year.

Detailed Description

This is a retrospective and prospective, non-randomized study of the Ceramic on Metal(CoM) device. This study will follow each subject through 10 years postoperatively. A total of 250 subjects will be enrolled in the investigation comprised of approximately 150 new PAS subjects and approximately 100 subjects recruited from the investigational device exemption study to the PAS.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
October 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • If the subject:
  • Was previously enrolled in the CoM IDE study with the Ceramic-on- Metal device, or
  • Qualifies based on the approved labeling for the device; and
  • Is willing and able to provide informed patient consent for participation in the PAS study; and
  • Is willing and able to return for follow-up as specified by the PAS study protocol; and
  • Is willing and able to complete the hip outcomes questionnaire as specified by the PAS study protocol. A patient will be considered a "Valid Study Subject" when he/she has
  • consented to participate,
  • authorized release of Personal Health Information (PHI),
  • met all eligibility criteria through the operative stage, and
  • received the implant as noted in this protocol.

Exclusion Criteria

  • Subjects will be excluded if, in the opinion of the investigator, the subject does not qualify based on approved labeling requirements or Subject Inclusion criteria.

Outcomes

Primary Outcomes

Survivorship

Time Frame: 10 years

Subjects will be seen each year through year 5 postoperatively for radiographic and clinical follow-up, and then at 8 and 10 years postoperatively for radiographic and clinical follow-up. Survivorship means the removal of either or both of the components (ceramic head or metal liner).

Secondary Outcomes

  • Metal Ion Levels(5 years, 8 years, and 10 years postoperatively)

Study Sites (2)

Loading locations...

Similar Trials